XML 46 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Investments (Tables)
 6 Months Ended
Jun. 30, 2020
Equity Method Investments and Joint Ventures [Abstract]  
Equity Method Investments The Company used the following summarized financial information for NantOmics for the three and six months ended March 31, 2020 and 2019, to record its equity method losses for the three and six months ended June 30, 2020 and 2019:
 
Three Months Ended
March 31,
 
Six Months Ended
March 31,
 
2020
 
2019
 
2020
 
2019
Revenues
$
126

 
$
1,320

 
$
349

 
$
3,066

Gross loss
(479
)
 
(814
)
 
(1,641
)
 
(1,334
)
Loss from operations
(3,950
)
 
(6,221
)
 
(7,806
)
 
(13,105
)
Impairment on equity investments
—

 
—

 
—

 
(12,265
)
Net loss
(1,258
)
 
(5,079
)
 
(2,618
)
 
(22,930
)
Net loss attributable to NantOmics
(1,230
)
 
(4,958
)
 
(2,559
)
 
(22,709
)